DoD Neurofibromatosis New Investigator Award

The summary for the DoD Neurofibromatosis New Investigator Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Neurofibromatosis New Investigator Award: The NFRP New Investigator Award mechanism (NIA) was created in FY99. Since then, 150 New Investigator Award proposals have been received, and 34 have been recommended for funding. The intent of the NFRP New Investigator Award is to support the career transition and/or continued development of promising independent investigators in the field of neurofibromatosis research. Eligible Principal Investigators (PIs) must be at or below the level of Assistant Professor (or equivalent), must have received no more than $300K in direct costs for NF research as a PI of a federally funded, non-mentored peer reviewed grant, and must have not received a NIA from any CDMRP program previously. Experience in NF research is allowed, but not required. However, PIs with a limited background in NF research are strongly encouraged to have a collaborator who is experienced in the NF field. Clinical trials are not acceptable under this mechanism. PIs wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. NIA proposals must include preliminary data relevant to NF and the proposed project. The FY08 NFRP encourages proposals that specifically address critical needs of the NF Community in the following areas: . Translational research such as the development or preclinical testing of therapeutic agents for the treatment of neurofibromatosis; . Complications of neurofibromatosis with high mortality such as childhood neoplasms, malignant peripheral nerve sheath tumors, and cerebrovascular abnormalities; . Complications of neurofibromatosis with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects and pain; . Refinement and standardization of imaging techniques and biomarkers for use in future clinical trials. Optional Collaborator: The FY08 NFRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the NF field are also strongly encouraged. These types of collaborations will qualify for a higher level of funding as described in Section II.D. For the proposal to qualify for the higher level of funding, the PI must submit a PI Statement of Collaboration in addition to the letter of collaboration from the collaborator. The PI Statement of Collaboration must clearly identify the collaborator and address the following requirements: . The collaborator must significantly contribute to the project such that the proposed work could not be accomplished without their involvement. . If the PI of the proposal does not have NF research experience, the collaborator must have experience in NF research as demonstrated through publications and/or funding history. . The collaborator must be at or above the level of Assistant Professor (or equivalent). . At least a 10% level of effort is required of the collaborator. Contribution of the collaborator should be reflected in the proposals budget.
Federal Grant Title: DoD Neurofibromatosis New Investigator Award
Federal Agency Name: Dept of the Army USAMRAA
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: W81XWH-08-NFRP-NIA
Type of Funding: Grant Cooperative Agreement
CFDA Numbers: 12.420
CFDA Descriptions: Military Medical Research and Development
Current Application Deadline: No deadline provided
Original Application Deadline: Apr 09, 2008
Posted Date: Feb 05, 2008
Creation Date: Feb 05, 2008
Archive Date: May 09, 2008
Total Program Funding: $1,350,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 2
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Helpdesk
Phone 301-619-7079 [email protected] CDMRP Helpdesk
Similar Government Grants
DoD Ovarian Cancer Ovarian Cancer Academy - Early-Career Investigator Award
DoD Peer Reviewed Medical, Impact Award
DoD Peer Reviewed Medical, Lifestyle and Behavioral Health Interventions Research Award
DoD Peer Reviewed Medical, Discovery Award
DoD Peer Reviewed Medical, Technology/Therapeutic Development Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Dept of the Army USAMRAA
DoD Peer Reviewed Medical, Impact Award
DoD Peer Reviewed Medical, Lifestyle and Behavioral Health Interventions Research Award
DoD Peer Reviewed Medical, Clinical Trial Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com